Published in Neurologist on January 01, 2009
Complications and controversies of regional anaesthesia: a review. Indian J Anaesth (2009) 1.35
Cerebrospinal fluid and lumbar puncture: a practical review. J Neurol (2012) 0.99
Cost comparison between the atraumatic and cutting lumbar puncture needles. Neurology (2011) 0.96
Postdural puncture headache in migraineurs and nonheadache subjects: a prospective study. Neurology (2013) 0.96
Consensus guidelines for lumbar puncture in patients with neurological diseases. Alzheimers Dement (Amst) (2017) 0.92
Postdural puncture headache and pregabalin. J Pain Res (2010) 0.87
Ultrasound guidance for lumbar puncture. Neurol Clin Pract (2016) 0.80
A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease. J Clin Neurol (2015) 0.79
Introduction of Sprotte needles to a single-centre acute neurology service: before and after study. JRSM Short Rep (2012) 0.76
Bone marrow elements in cerebrospinal fluid: Review of literature with a case study. Cytojournal (2013) 0.76
CT-guided spinal injection: initial experience with Sprotte tip needles. Neuroradiology (2009) 0.75
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol (2006) 2.67
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol (2008) 2.58
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol (2013) 2.46
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology (2013) 2.34
Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc (2004) 2.29
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Barriers to telemedicine: survey of current users in acute care units. Telemed J E Health (2011) 1.94
Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc (2003) 1.80
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke (2009) 1.63
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47
Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada. Stroke (2007) 1.46
Cerebral ischemic events associated with 'bubble study' for identification of right to left shunts. Stroke (2009) 1.44
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol (2012) 1.40
Neuromyelitis optica: changing concepts. J Neuroimmunol (2007) 1.39
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol (2009) 1.27
Herbal medicine use in parturients. Anesth Analg (2002) 1.18
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Clinical practice. Transverse myelitis. N Engl J Med (2010) 1.17
NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers (2006) 1.14
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve (2009) 1.13
The state of emergency stroke resources and care in rural Arizona: a platform for telemedicine. Telemed J E Health (2009) 1.12
Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc (2009) 1.12
Neuromyelitis optica. Curr Opin Neurol (2007) 1.10
Cost-effectiveness of hub-and-spoke telestroke networks for the management of acute ischemic stroke from the hospitals' perspectives. Circ Cardiovasc Qual Outcomes (2012) 1.09
Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 1.09
Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord (2012) 1.08
Telemedicine versus telephone for remote emergency stroke consultations: a critically appraised topic. Neurologist (2009) 1.06
Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke (2009) 1.05
Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Stroke (2007) 1.01
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist (2007) 0.98
Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist (2009) 0.97
Ancrod in acute ischemic stroke: results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program. Stroke (2009) 0.96
A systematic review of telestroke. Postgrad Med (2013) 0.94
Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist (2008) 0.93
Systematic review of teleneurology: methodology. Front Neurol (2012) 0.92
Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis (2009) 0.91
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic. Neurologist (2012) 0.90
Forearm compartment syndrome following intravenous thrombolytic therapy for acute ischemic stroke. Neurocrit Care (2005) 0.90
The two faces of neuromyelitis optica. Neurology (2014) 0.89
New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic. Neurologist (2012) 0.89
Sepsis and acute renal failure in pregnancy. Anesth Analg (2009) 0.87
Epidural saline to facilitate Arrow Flex-Tip epidural catheter removal. Anesth Analg (2011) 0.87
Assessment of emergency medical technicians serving the Phoenix metropolitan matrix of primary stroke centers. Stroke (2007) 0.86
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist (2007) 0.86
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist (2007) 0.86
Pain relief during labor. N Engl J Med (2005) 0.86
OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol (2006) 0.85
Prophylactic ephedrine and combined spinal epidural: maternal blood pressure and fetal heart rate patterns. Obstet Gynecol (2005) 0.85
Does cervical manipulative therapy cause vertebral artery dissection and stroke? Neurologist (2008) 0.85
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist (2011) 0.85
Neuromyelitis optica spectrum disorders. Continuum (Minneap Minn) (2010) 0.84
Systematic review of telestroke for post-stroke care and rehabilitation. Curr Atheroscler Rep (2013) 0.84
Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist (2008) 0.84
Regional anesthesia in parturients with low platelet counts. Can J Anaesth (2005) 0.84
Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topic. Neurologist (2009) 0.84
Diagnosis of pulmonary arteriovenous malformation using a transesophageal echocardiography bubble study. Eur J Echocardiogr (2011) 0.84
Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic. Neurologist (2010) 0.84
Telestroke network business model strategies. J Stroke Cerebrovasc Dis (2012) 0.84
Identification of stroke mimics in the emergency department setting. J Brain Dis (2009) 0.84
Is dabigatran cost effective compared with warfarin for stroke prevention in atrial fibrillation? A critically appraised topic. Neurologist (2012) 0.83
Treatment of vascular dementia and vascular cognitive impairment. Neurologist (2007) 0.83
Future neurohospitalist: teleneurohospitalist. Neurohospitalist (2012) 0.83
Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic. Neurologist (2010) 0.83
Seamless integrated stroke telemedicine systems of care: a potential solution for acute stroke care delivery delays and inefficiencies. Stroke (2011) 0.82
Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth. Neurologist (2007) 0.82
Views of emergency physicians on thrombolysis for acute ischemic stroke. J Brain Dis (2009) 0.82
Comment: Costs and consequences of atraumatic dural puncture needles. Neurology (2011) 0.82
Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic. Neurologist (2007) 0.82
The role of corticosteroids in the management of chronic subdural hematomas: a critically appraised topic. Neurologist (2009) 0.82